[HTML][HTML] A review of broadly protective monoclonal antibodies to treat Ebola virus disease

P Rijal, FR Donnellan - Current Opinion in Virology, 2023 - Elsevier
Highlights•mAbs mixture targeting independent epitopes are better therapeutics.•Optimizing
antibody efficacy: in vitro maturation, afucosylation, Fc modifications.•Monitoring of natural …

Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation

LC Dupuy, CF Spiropoulou, JS Towner… - The Journal of …, 2023 - academic.oup.com
Viruses in the family Filoviridae, including the commonly known Ebola (EBOV) and Marburg
(MARV) viruses, can cause severe hemorrhagic fever in humans and nonhuman primates …

[PDF][PDF] Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses

JC Milligan, CW Davis, X Yu, PA Ilinykh, K Huang… - Cell, 2022 - cell.com
Several ebolaviruses cause outbreaks of severe disease. Vaccines and monoclonal
antibody cocktails are available to treat Ebola virus (EBOV) infections, but not Sudan virus …

Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody

R Stass, TB Engdahl, NS Chapman, RM Wolters… - Nature …, 2023 - nature.com
Rodent-borne hantaviruses are prevalent worldwide and upon spillover to human
populations, cause severe disease for which no specific treatment is available. A potent …

Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies

TB Engdahl, E Binshtein, RL Brocato, NA Kuzmina… - Elife, 2023 - elifesciences.org
Hantaviruses are high-priority emerging pathogens carried by rodents and transmitted to
humans by aerosolized excreta or, in rare cases, person-to-person contact. While infections …

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques

C Woolsey, AC Fears, V Borisevich… - Emerging Microbes & …, 2022 - Taylor & Francis
Due to its high mortality rate and continued re-emergence, Ebolavirus disease (EVD)
continues to pose a serious threat to global health. A group of viruses within the genus …

A Pan-ebolavirus Monoclonal Antibody Cocktail Provides Protection against Ebola and Sudan Viruses

G Liu, S He, M Chan, Z Zhang, H Schulz… - The Journal of …, 2023 - academic.oup.com
Filoviruses, including ebolaviruses and marburgviruses, can cause severe and often fatal
disease in humans. Over the past several years, antibody therapy has emerged as a …

Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection

H Tamir, T Noy-Porat, S Melamed… - Nature …, 2024 - nature.com
The eradication of smallpox was officially declared by the WHO in 1980, leading to
discontinuation of the vaccination campaign against the virus. Consequently, immunity …

[HTML][HTML] Real-time cell analysis: a high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape

N Suryadevara, P Gilchuk, SJ Zost, N Mittal, LL Zhao… - STAR protocols, 2022 - Elsevier
Real-time cell analysis (RTCA) enables high-throughput, quantitative kinetic measurements
of cytopathic effect (CPE) in virus-infected cells. Here, we detail a RTCA approach for …

Development and structural analysis of antibody therapeutics for filoviruses

X Yu, EO Saphire - Pathogens, 2022 - mdpi.com
The filoviruses, including ebolaviruses and marburgviruses, are among the world's deadliest
pathogens. As the only surface-exposed protein on mature virions, their glycoprotein GP is …